Generic Drugmakers to Inherit Safety Labeling Update Powers Under FDA Rule

Generic Line
The FDA is proposing to give generic drugmakers the power to revise product labeling in response to safety issues prior to agency approval — a power that brand drugmakers already have.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00